🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?Explore for Free

Australia regulator approves Pfizer vaccine for children 5-11

Published 12/04/2021, 06:07 PM
Updated 12/04/2021, 10:10 PM
© Reuters. FILE PHOTO: A healthcare professional prepares a dose of the Pfizer coronavirus disease (COVID-19) vaccine as high-risk workers receive the first vaccines in the state of Victoria's rollout of the program, in Melbourne, Australia, February 22, 2021.  REUT
PFE
-

By Lidia Kelly

MELBOURNE (Reuters) - Australia's medicine regulator on Sunday provisionally approved the Pfizer Inc (NYSE:PFE) coronavirus vaccine for children between the ages of 5 and 11, with the health minister saying the rollout could begin from Jan. 10.

The Therapeutics Goods Administration "have made a careful, thorough assessment, determined that it is safe and effective and that it is in the interests of children and Australians for children 5 to 11 to be vaccinated," said Health Minister Greg Hunt.

After initial delays with its general COVID-19 inoculation programme, Australia has swiftly become one of the world's most-vaccinated countries, with nearly 88% of Australians over the age of 16 having received two doses.

The high vaccination has helped slow the spread of the virus and promote a speedy economic recovery, with the government planning to raise its 2022 growth forecast within weeks.

The efficacy of vaccines against the new Omicron variant, which is spreading in Australia, remains unknown.

The most populous state, New South Wales, reported two more Omicron cases on Sunday, bringing the total to 15 cases, and the Australian Capital Territory confirmed its second.

Parliament House was closed over the weekend to the public until further notice after a staffer to a member of parliament tested positive to COVID-19 after the legislature's final sitting week of the year on Friday.

The variant of that infection case has not been disclosed, but health authorities said the staff was fully vaccinated.

While nationwide vaccinations are voluntary, states and territories have mandated shots for many occupations, and some require full vaccination to access most hospitality services and non-essential retail.

Australia's overall childhood immunisation coverage is also one of the highest in the world, with 95% of 5-year-olds inoculated with vaccines recommended for their age, health data showed.

The Pfizer vaccine for those children still needs the approval of the Australian Technical Advisory Group on Immunisation. Once approved, it will be available to about 2.3 million children in the 5-to-11 age group.

© Reuters. FILE PHOTO: A healthcare professional prepares a dose of the Pfizer coronavirus disease (COVID-19) vaccine as high-risk workers receive the first vaccines in the state of Victoria's rollout of the program, in Melbourne, Australia, February 22, 2021.  REUTERS/Sandra Sanders

Despite battling many outbreaks this year, leading to months of lockdown in Sydney and Melbourne - Australia's largest cities - the country has had only about 834 confirmed COVID-19 cases and 7.9 deaths per 100,000 people, according to the World Health Organisation, a fraction of the toll in many other developed nations.

Australia has had just under 217,000 cases in total and 2,042 deaths.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.